QIMA Life Sciences is a Contract Research Organization (CRO) established in 1996 and specializing in cellular and molecular pharmacology. Since 2022, the company brings together QIMA Bioalternatives, QIMA Synelvia, Newtone Technologies and Monasterium Laboratory.
We offer assays ranging from in silico screening to clinical imaging, as well as in vitro and ex vivo assays and non-invasive clinical sample bioanalysis. QIMA Life Sciences also offers the exclusive “Blood assay solutions” for fresh whole blood testing.
QIMA Life Sciences contributes to the development of in vitro methods as an alternative to animal experimentation, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations.
Beyond this activity of product evaluation and development and thanks to our offer of customized competitive services based on collaborative innovation, QIMA Life Sciences can assist the health industry with its new strategic choices.
Our assays are performed on our three French sites, Gençay (Vienne), Labège (Haute-Garonne) and Lyon (Rhône-Alpes) and in Germany, on our site located in Münster (North Rhine-Westphalia).
With 100 experts and four laboratories of more than 2000 square metres, our firm helps the marketing and R&D departments of big International cosmetic and pharmaceutical groups to innovate in the field of project conceptualization and to substantiate and support their product claims.
